Ping An Biomedical Co., Ltd. (PASW) stock forecast & analysis
0.1516
NasdaqCM · USD
Up: +0.0187, +14.1%
1 analysis
- Open
- 0.1400
- Previous close
- 0.1329
- Day range
- 0.1308 – 0.2400
- 52-week range
- 0.1100 – 1.54
- Volume (shares)
- 345.75M
- Net assets
- Not available
- Expense ratio
- Not available
- Shares outstanding
- 124.55M
- P/E ratio
- Not available
- Dividend yield
- Not available
- Beta
- Not available
- Market cap
- 18.88M
Market Scanner’s AI analysis of Ping An Biomedical Co., Ltd. (PASW), updated September 2026: PASW's recent coverage focused on a strategic cooperation agreement and mixed technical indicators against a backdrop of declining financials.
Summary
PASW's recent coverage focused on a strategic cooperation agreement and mixed technical indicators against a backdrop of declining financials.
Recent analyses for PASW covered a new strategic cooperation agreement aimed at achieving RMB 500 million in sales over three years. This news comes as the company exhibits mixed technical signals, with strong short-term positive momentum contrasting with a significant long-term bearish trend. Financially, the company reported a substantial year-over-year revenue decrease and negative profit margins.
PASW news & sentiment
News coverage highlighted a new strategic cooperation agreement, while social media discussions showed mixed sentiment with some positive short-term price momentum countered by long-term bearish technical trends and negative financial performance.
PASW technical picture
PASW's price action showed a positive short-term trend with a 7-day and 30-day increase, though a longer-term decline was noted over 91 days. The price sat above its 50-day moving average but significantly below its 200-day moving average. Momentum indicators like RSI and MFI suggested strong buying pressure.
Fundamentals
The company reported a substantial year-over-year revenue decrease and negative profit and operating margins. Shareholder equity has been volatile, fluctuating between positive and negative values. Cash flow from operations has also been volatile.
Factors discussed — upside
- 7-day price change of +12.6%
- 30-day price change of +25.6%
- Price above 50-day SMA
- RSI at 61.88 indicating bullish momentum
- MFI at 99.91 suggesting strong buying pressure
Factors discussed — risks
- 91-day price change of -3.8%
- Price significantly below 200-day SMA
- Negative Earnings Per Share (EPS) of -$0.12
- Profit Margin of -37.57%
- Operating Margin (TTM) of -69.64%
- Technical indicators
- Financial health
- Strategic cooperation
- Revenue trends
Summary updated .
PASW technical indicators
Common technical indicators for PASW, computed from its daily closing prices.
| Indicator | Value | Reading |
|---|---|---|
| 50-day simple moving average | 0.14 | Price above |
| 10-day exponential moving average | 0.14 | Price above |
| Relative strength index (14-day) | 61.89 | Neutral |
| MACD line (12/26/9) | 0.0009 | Above its signal line |
| Bollinger bands (20-day, 2σ) | 0.12 – 0.15 | Price above the upper band |
Analyses
Recent PASW.US analyses are locked — sign in to read them or generate a fresh one.
Frequently asked questions
- What is the bull case for Ping An Biomedical Co., Ltd.?
- The analyses discussed positive short-term price momentum, evidenced by recent gains and the price trading above its 50-day moving average. Strong buying pressure was indicated by a high Money Flow Index, alongside a Relative Strength Index above neutral levels.
- What are the risks for Ping An Biomedical Co., Ltd.?
- The company faces headwinds from a longer-term bearish price trend and a significant year-over-year revenue decrease. Analyses also highlighted negative profit and operating margins, alongside a substantial amount of total debt relative to cash.
- Is Ping An Biomedical Co., Ltd. bullish or bearish?
- Recent AI analyses of Ping An Biomedical Co., Ltd. examined factors on both sides. Discussed upside: The analyses discussed positive short-term price momentum, evidenced by recent gains and the price trading above its 50-day moving average. Strong buying pressure was indicated by a high Money Flow Index, alongside a Relative Strength Index above neutral levels. Discussed risks: The company faces headwinds from a longer-term bearish price trend and a significant year-over-year revenue decrease. Analyses also highlighted negative profit and operating margins, alongside a substantial amount of total debt relative to cash. These are descriptive observations, not a recommendation.
- What is the latest sentiment on Ping An Biomedical Co., Ltd.?
- News coverage highlighted a new strategic cooperation agreement, while social media discussions showed mixed sentiment with some positive short-term price momentum countered by long-term bearish technical trends and negative financial performance.
- Bundles used
- gemini-low-v2
Run a fresh PASW.US analysis
Configure the ticker, model bundle and debate depth here — you only sign in at the end, and everything you picked comes with you.
Or sign in to read every PASW.US report already in the library